Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-24-134828

Chief Executive Officer bought 10,296 shares at $1.94 ($19,974)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Imran Talat Chief Executive Officer 2024-12-09 Purchase +10,296 $1.94 $19,974 494,751 D: show line 1 in the form
Open-market purchases · 10,296 sh · avg $1.94 · $19,974
Loading xslF345X05/ownership.xml…